Literature DB >> 26546683

Comment on "Primary Central Nervous System (CNS) Lymphoma B Cell Receptors Recognize CNS Proteins".

Elmar Spies1, Michael Fichtner2, Fabian Müller3, Susanne Krasemann4, Gerald Illerhaus5, Markus Glatzel4, Mascha Binder2, Martin Trepel6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26546683     DOI： 10.4049/jimmunol.1501964

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  3 in total

1.  Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.

Authors:  Christian Grommes; Alessandro Pastore; Nicolaos Palaskas; Sarah S Tang; Carl Campos; Derrek Schartz; Paolo Codega; Donna Nichol; Owen Clark; Wan-Ying Hsieh; Dan Rohle; Marc Rosenblum; Agnes Viale; Viviane S Tabar; Cameron W Brennan; Igor T Gavrilovic; Thomas J Kaley; Craig P Nolan; Antonio Omuro; Elena Pentsova; Alissa A Thomas; Elina Tsyvkin; Ariela Noy; M Lia Palomba; Paul Hamlin; Craig S Sauter; Craig H Moskowitz; Julia Wolfe; Ahmet Dogan; Minhee Won; Jon Glass; Scott Peak; Enrico C Lallana; Vaios Hatzoglou; Anne S Reiner; Philip H Gutin; Jason T Huse; Katherine S Panageas; Thomas G Graeber; Nikolaus Schultz; Lisa M DeAngelis; Ingo K Mellinghoff
Journal:  Cancer Discov       Date:  2017-06-15       Impact factor: 39.397

2.  The process of somatic hypermutation increases polyreactivity for central nervous system antigens in primary central nervous system lymphoma.

Authors:  Manuel Montesinos-Rongen; Monica Terrao; Caroline May; Katrin Marcus; Ingmar Blümcke; Martin Hellmich; Ralf Küppers; Anna Brunn; Martina Deckert
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

Review 3.  Impact of a Faulty Germinal Center Reaction on the Pathogenesis of Primary Diffuse Large B Cell Lymphoma of the Central Nervous System.

Authors:  Manuel Montesinos-Rongen; Anna Brunn; Monica Sanchez-Ruiz; Ralf Küppers; Reiner Siebert; Martina Deckert
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.